APA

Nishikawa S., Okamura A., Yamamori M., Minagawa K., Kawamori Y., Kawano Y., Kawano H., Ono K., Katayama Y., Shimoyama M. & Matsui T. (20100224). Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. : Transplantation proceedings.

Chicago

Nishikawa S, Okamura A, Yamamori M, Minagawa K, Kawamori Y, Kawano Y, Kawano H, Ono K, Katayama Y, Shimoyama M and Matsui T. 20100224. Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. : Transplantation proceedings.

Harvard

Nishikawa S., Okamura A., Yamamori M., Minagawa K., Kawamori Y., Kawano Y., Kawano H., Ono K., Katayama Y., Shimoyama M. and Matsui T. (20100224). Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. : Transplantation proceedings.

MLA

Nishikawa S, Okamura A, Yamamori M, Minagawa K, Kawamori Y, Kawano Y, Kawano H, Ono K, Katayama Y, Shimoyama M and Matsui T. Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. : Transplantation proceedings. 20100224.